DISARM EU

DISARM EU is dedicated to revolutionizing hereditary ovarian cancer (OC) risk assessment and early detection throughout Europe. As a leading entity in the Hospitals and Health Care sector, DISARM EU addresses critical gaps in personalized risk assessment and the need for accessible tools for early OC detection. The organization is committed to validating affordable, minimally invasive diagnostic technologies and deploying intelligent digital assets to empower healthcare providers, patients, and policymakers.

Through a combination of clinical studies, digital innovation, and active stakeholder engagement, DISARM EU strives to integrate its advanced solutions into routine care across numerous countries. The organization’s work, funded by the European Union’s Horizon Europe Research and Innovation Programme, underscores its dedication to advancing healthcare and improving patient outcomes in the fight against ovarian cancer.

DISARM EU is poised to make a significant impact on healthcare across Europe. We invite the management team at DISARM EU to create a customized and exclusive company showcase and product listing on our platform to further highlight their contributions and expand their reach.